BIOMAT Database Logo BIOMAT Database Logo

Clinical significance of tricyclic antidepressant plasma levels. 1979

J J Silverman, and P Brennan, and R O Friedel

UI MeSH Term Description Entries
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000929 Antidepressive Agents, Tricyclic Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system. Antidepressants, Tricyclic,Tricyclic Antidepressant,Tricyclic Antidepressant Drug,Tricyclic Antidepressive Agent,Tricyclic Antidepressive Agents,Antidepressant Drugs, Tricyclic,Agent, Tricyclic Antidepressive,Agents, Tricyclic Antidepressive,Antidepressant Drug, Tricyclic,Antidepressant, Tricyclic,Antidepressive Agent, Tricyclic,Drug, Tricyclic Antidepressant,Drugs, Tricyclic Antidepressant,Tricyclic Antidepressant Drugs,Tricyclic Antidepressants

Related Publications

J J Silverman, and P Brennan, and R O Friedel
Tricyclic antidepressant overdose: clinical presentation and plasma levels.
November 1975, Clinical pharmacology and therapeutics,
J J Silverman, and P Brennan, and R O Friedel
Monitoring tricyclic antidepressant plasma levels.
May 1984, American family physician,
J J Silverman, and P Brennan, and R O Friedel
Clinical significance of plasma levels of tricyclic antidepressant drugs in the treatment of depression.
March 1973, Lancet (London, England),
J J Silverman, and P Brennan, and R O Friedel
Relevancy of tricyclic antidepressant plasma levels.
April 1981, The American journal of psychiatry,
J J Silverman, and P Brennan, and R O Friedel
Amitriptyline overdose: clinical effects on tricyclic antidepressant plasma levels.
November 1982, The Journal of clinical psychiatry,
J J Silverman, and P Brennan, and R O Friedel
Tricyclic antidepressant plasma levels in overdose.
February 1981, JAMA,
J J Silverman, and P Brennan, and R O Friedel
Benzodiazepines and tricyclic antidepressant plasma levels.
July 1973, British medical journal,
J J Silverman, and P Brennan, and R O Friedel
The clinical application of tricyclic antidepressant pharmacokinetics and plasma levels.
June 1980, The American journal of psychiatry,
J J Silverman, and P Brennan, and R O Friedel
Therapeutic implications of tricyclic antidepressant plasma levels.
June 1976, The Journal of nervous and mental disease,
J J Silverman, and P Brennan, and R O Friedel
Tricyclic antidepressant plasma levels after fluoxetine addition.
January 1992, Neuropsychobiology,
Copied contents to your clipboard!